352 related articles for article (PubMed ID: 24854884)
1. In vitro and in vivo topical delivery studies of tretinoin-loaded ultradeformable vesicles.
Ascenso A; Salgado A; Euletério C; Praça FG; Bentley MV; Marques HC; Oliveira H; Santos C; Simões S
Eur J Pharm Biopharm; 2014 Sep; 88(1):48-55. PubMed ID: 24854884
[TBL] [Abstract][Full Text] [Related]
2. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
[TBL] [Abstract][Full Text] [Related]
3. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
4. Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach.
Ascenso A; Cruz M; Euletério C; Carvalho FA; Santos NC; Marques HC; Simões S
J Liposome Res; 2013 Sep; 23(3):211-9. PubMed ID: 23631723
[TBL] [Abstract][Full Text] [Related]
5. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
[TBL] [Abstract][Full Text] [Related]
6. Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery.
Barone A; Cristiano MC; Cilurzo F; Locatelli M; Iannotta D; Di Marzio L; Celia C; Paolino D
Colloids Surf B Biointerfaces; 2020 Sep; 193():111152. PubMed ID: 32535351
[TBL] [Abstract][Full Text] [Related]
7. Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles.
Paolino D; Cosco D; Cilurzo F; Trapasso E; Morittu VM; Celia C; Fresta M
J Control Release; 2012 Aug; 162(1):143-51. PubMed ID: 22698941
[TBL] [Abstract][Full Text] [Related]
8. The ameliorated longevity and pharmacokinetics of valsartan released from a gel system of ultradeformable vesicles.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1457-63. PubMed ID: 25953248
[TBL] [Abstract][Full Text] [Related]
9. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
Zhu X; Li F; Peng X; Zeng K
Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
[TBL] [Abstract][Full Text] [Related]
11. Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery.
Cosco D; Paolino D; Maiuolo J; Marzio LD; Carafa M; Ventura CA; Fresta M
Int J Pharm; 2015 Jul; 489(1-2):1-10. PubMed ID: 25899287
[TBL] [Abstract][Full Text] [Related]
12. Lipid vesicles and other colloids as drug carriers on the skin.
Cevc G
Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
[TBL] [Abstract][Full Text] [Related]
13. Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation.
Calienni MN; Temprana CF; Prieto MJ; Paolino D; Fresta M; Tekinay AB; Alonso SDV; Montanari J
Drug Deliv Transl Res; 2018 Jun; 8(3):496-514. PubMed ID: 29288359
[TBL] [Abstract][Full Text] [Related]
14. Liposomes and niosomes as topical drug delivery systems.
Choi MJ; Maibach HI
Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019
[TBL] [Abstract][Full Text] [Related]
15. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles.
Fresta M; Puglisi G
J Drug Target; 1996; 4(2):95-101. PubMed ID: 8894969
[TBL] [Abstract][Full Text] [Related]
16. Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant.
Essa EA; Bonner MC; Barry BW
J Control Release; 2004 Mar; 95(3):535-46. PubMed ID: 15023464
[TBL] [Abstract][Full Text] [Related]
17. Design and Optimization of Cationic Nanocapsules for Topical Delivery of Tretinoin: Application of the Box-Behnken Design,
Ebrahimi S; Mahjub R; Haddadi R; Vafaei SY
Biomed Res Int; 2021; 2021():4603545. PubMed ID: 34934769
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy.
Raminelli ACP; Romero V; Semreen MH; Leonardi GR
Curr Med Chem; 2018; 25(31):3703-3718. PubMed ID: 29532749
[TBL] [Abstract][Full Text] [Related]
19. Statistical optimization of tretinoin-loaded penetration-enhancer vesicles (PEV) for topical delivery.
Bavarsad N; Akhgari A; Seifmanesh S; Salimi A; Rezaie A
Daru; 2016 Feb; 24():7. PubMed ID: 26926453
[TBL] [Abstract][Full Text] [Related]
20. Calcipotriol delivery into the skin with PEGylated liposomes.
Knudsen NØ; Rønholt S; Salte RD; Jorgensen L; Thormann T; Basse LH; Hansen J; Frokjaer S; Foged C
Eur J Pharm Biopharm; 2012 Aug; 81(3):532-9. PubMed ID: 22538098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
